✦ LIBER ✦

Biocontrol—risky but necessary?

✍ Scribed by M.B Thomas; A.J Willis

Book ID: 117389318
Publisher: Elsevier Science
Year: 1998
Tongue: English
Weight: 94 KB
Volume: 13
Category: Article
ISSN: 0169-5347
DOI: 10.1016/s0169-5347(98)01417-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical trials risky but necessary

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Triple Antithrombotic Therapy: Risky but

Triple Antithrombotic Therapy: Risky but Sometimes Necessary

✍ Sørensen, Rikke; Gislason, Gunnar 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 249 KB

Aprotinin: Effective, but risky?

✍ James D. Perkins 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 81 KB

Background: The majority of patients undergoing surgical treatment for ST-elevation myocardial infarction receive antifibrinolytic therapy to limit blood loss. This approach appears counterintuitive to the accepted medical treatment of the same conditionnamely, fibrinolysis to limit thrombosis. Desp

Regeneration: Rewarding, but potentially

Regeneration: Rewarding, but potentially risky

✍ Bernhard Egger 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 391 KB

Geothermal energy promising but risky

📂 Article 📅 1976 🏛 American Chemical Society 🌐 English ⚖ 320 KB

Necessary but insufficient

✍ Papermaster, David S. 📂 Article 📅 1995 🏛 Nature Publishing Group 🌐 English ⚖ 226 KB